EGFR and cancer: It was reported that lovastatin inhibited EGF-induced EGFR autophosphorylation and its downstream signaling, and the combined treatment of gefitinib with lovastatin induced synergistic anti-proliferative and pro-apoptotic effects in cancer cell lines, including NSCLC cells [115].